Latest News

June 24, 2013
A UCSF-led research team has identified the likely genetic mechanism that causes some patients with multiple sclerosis to quickly progress to a debilitating stage of the disease while other patients progress much more slowly.
June 24, 2013
Gene mutations that lead to major birth defects may also cause subtle disruptions in the brain that contribute to psychiatric disorders such as schizophrenia, autism and bipolar disorder, according to new research by UCSF scientists.
June 18, 2013
Researchers at the UCSF-affiliated Gladstone Institutes have discovered how one important protein falls under direct instructions from the body’s circadian clock and how this protein regulates fundamental circadian processes.
June 09, 2013
Scientists at the Gladstone Institutes have deciphered how a protein called Arc regulates the activity of neurons – providing much-needed clues into the brain’s ability to form long-lasting memories.
May 08, 2013
A new application of an existing medical imaging technology could help predict long-term damage in patients with traumatic brain injury, according to a recent UCSF study.
May 07, 2013
A key type of human brain cell developed in the laboratory grows seamlessly when transplanted into the brains of mice, UCSF researchers have found.
May 07, 2013
Epilepsy that does not respond to drugs can be halted in adult mice by transplanting a specific type of cell into the brain, UCSF researchers have discovered, raising hope that a similar treatment might work in severe forms of human epilepsy.
May 01, 2013
A UCSF-led research team has identified a genetic mutation that is strongly associated with a typical form of migraine. The discovery could lead to more effective therapies for people with this condition.
April 08, 2013
A Phase 2 clinical trial testing a new protocol for treating a relatively rare form of brain cancer, primary CNS lymphoma, may change the standard of care for this disease, according to UCSF doctors who led the research.
April 02, 2013
President Barack Obama has unveiled a bold public-private initiative to map the brain to gain greater insight on how we think, learn and remember and to better understand and treat diseases ranging from autism to schizophrenia.

Pages